2 results
Approved WMOCompleted
The primary objective of the study is to demonstrate the antitumor activity of LDK378.
Approved WMORecruiting
1. The primary objectives of this phase I/II clinical trial is to demonstrate feasibility and evaluate the safety and toxicity of ACT plus vaccination according to CTCAE 4.0 criteria.2. Secondary objectives include the evaluation of the clinical…